How Robotic Technology Control Is Driving the Future of Neurotechnology cover art

How Robotic Technology Control Is Driving the Future of Neurotechnology

How Robotic Technology Control Is Driving the Future of Neurotechnology

Listen for free

View show details

About this listen

Dr. Connor Glass is the Founder of Phantom Neuro, a neurotechnology company enabling lifelike control of robotic orthopedic technologies, including prosthetic limbs and exoskeletons. As a physician and bionic interfacing researcher, he specializes in microsurgical interventions for nerve injury and connecting machines to the nervous system. Dr. Glass augments biology with technology for function restoration, human augmentation, and life extension. 

In this episode…

Neurotechnology has adapted to harness AI-powered implants and robotic prosthetics. Academic fellows and medical school residents have made significant strides in human-machine interfacing and augmentation research. Yet these discoveries are often retained by the research organization or academic institution and are rarely commercialized. How can you transform your idea into an influential product?

Physician, entrepreneur, and neurotechnology researcher Dr. Connor Glass acquired a team of commercial entities, academic partners, and strategic advisors to conceive, build, and launch a platform controlling prosthetic orthopedic technologies. But navigating IP logistics, raising capital, and facilitating widespread accessibility is arduous, so Dr. Glass says to structure your patents with general and initial ideas before refining and detailing your designs. He targets a broad market to promote global impact and reduce costs.

Phantom Neuro’s Founder, Dr. Connor Glass, joins JiNan Glasgow George in this episode of Own Your Zone Podcast to discuss how he’s revolutionizing the neurotechnology industry. Dr. Glass talks about how he transformed his idea into a commercial product, his vision for human augmentation, and how he built a team of diverse professionals to cultivate and iterate his IP patents.

No reviews yet